Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?
about
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial PhenotypeEmerging Transcriptional Mechanisms in the Regulation of Epithelial to Mesenchymal Transition and Cellular Plasticity in the KidneyRole of EMT in Metastasis and Therapy ResistanceEpithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention SolutesThe FOXD1 lineage of kidney perivascular cells and myofibroblasts: functions and responses to injuryToll-like receptor activation: from renal inflammation to fibrosisEMT and interstitial lung disease: a mysterious relationshipDiverse functions of matrix metalloproteinases during fibrosisInhibitors/antagonists of TGF-β system in kidney fibrosisHost responses in tissue repair and fibrosisRenal pericytes: regulators of medullary blood flowAngiotensin II contributes to renal fibrosis independently of Notch pathway activationMesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal DialysisGenetic tools for identifying and manipulating fibroblasts in the mousePiceatannol Attenuates Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Downregulation of Histone Deacetylase 4/5 or p38-MAPK SignalingEmerging targets in lipid-based therapyThe Current State of Peritoneal DialysisTransforming growth factor-β1 receptor inhibition preserves glomerulotubular integrity during ureteral obstruction in adults but worsens injury in neonatal miceFight-or-flight: murine unilateral ureteral obstruction causes extensive proximal tubular degeneration, collecting duct dilatation, and minimal fibrosisNephrons require Rho-kinase for proximal-distal polarity developmentEsophageal epithelial cells acquire functional characteristics of activated myofibroblasts after undergoing an epithelial to mesenchymal transition.Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosisSalt Loading Promotes Kidney Injury via Fibrosis in Young Female Ren2 Rats.Cellular and molecular mechanisms in kidney fibrosis.Role of the Wnt/β-catenin signaling pathway in inducing apoptosis and renal fibrosis in 5/6-nephrectomized ratsOrigin and function of myofibroblasts in kidney fibrosis.Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis.miR-382 Contributes to Renal Tubulointerstitial Fibrosis by Downregulating HSPD1.Defective CFTR leads to aberrant β-catenin activation and kidney fibrosis.Metformin ameliorates the Phenotype Transition of Peritoneal Mesothelial Cells and Peritoneal Fibrosis via a modulation of Oxidative Stress.Akt2 is involved in loss of epithelial cells and renal fibrosis following unilateral ureteral obstruction.Distinct mesenchymal alterations in N-cadherin and E-cadherin positive primary renal epithelial cellsSecreted Frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy.Role of moesin in renal fibrosis.Angiotensin-(1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2.Norcantharidin inhibits renal interstitial fibrosis by blocking the tubular epithelial-mesenchymal transition.Therapeutic targets for treating fibrotic kidney diseasesTransition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander?Myo/Nog cells: targets for preventing the accumulation of skeletal muscle-like cells in the human lens.
P2860
Q26765903-565C44EB-9156-4436-9EB3-5F37AB119496Q26771698-1BAE54C2-15EE-4EAF-9A5B-3CEF64755B1DQ26772923-81F6C5C9-A81D-423E-B1B9-A5656BAB72ABQ26782283-04C42EA9-A7F4-4ADF-BB56-437CF6E37F98Q26784008-D364EBB2-9B59-4E10-83C5-D268A551B282Q26796637-80086455-9795-4BE8-AFF4-67E4E63E149AQ26796639-A39A7193-4DAC-4566-9E6B-B5FC3D4485ADQ26824760-24F18CFA-6F7E-4955-B87A-EEE89AE81B1DQ26825368-FE468A24-1562-441B-8BB5-7562D12BDDA9Q26852400-9613B1AF-57FD-4021-BB1B-E170570FFF54Q26852800-2759537E-83B8-4715-A7EA-FC44DD6794DBQ26863552-AC1E364F-C4C5-433A-9BB9-2DE8E6676D19Q27334791-BC801F3D-FD87-43C1-BB5E-E1DF59A8D6B6Q28390104-B0B3B5BC-B51C-4514-8BE5-1402845ED8FDQ28392538-049526B1-278A-4D02-AB25-B52CA7BFD95BQ28554628-BEEBB697-854A-45D0-BFDD-2B28D2776291Q28655456-33A179D4-F46B-4A85-AAE1-1F696441C8A0Q30243902-C9ECF607-0333-4F37-A80D-60D67FFE2671Q30414456-29BEA117-D9C6-40E9-BEC7-26B53A0830FEQ30418407-EFFEABE6-A75E-4461-A26E-562FE450B5DEQ30544951-FBBF7326-C9CE-406C-AB5F-2DD4F9D5A90CQ30656354-0E7113C7-9F22-41A9-8A71-C4878FAC640BQ33569405-85A74746-7194-47E5-8DDF-138C032CF32EQ33628045-9C648046-AA8C-4342-8473-14EAF5EC15E2Q33685938-B449DAD3-2040-44C4-8A2B-3244F328DC42Q33702273-39FB1FD7-D1A1-4163-A941-65E6FFDBFCFCQ33792700-43018083-D22E-492A-AEB4-64CAE6C7B308Q33808347-67DC4448-7BAF-48DB-AAE0-5E3E3AA04A9BQ33820023-A6E4A79D-DCB6-42B1-82A3-59CF00609173Q33899411-CB45DB27-7DDA-4B0A-A38F-C2433C7FF73EQ33915937-746F2580-ED8D-4030-BE50-AD7EF06D0787Q34078703-E208D9DD-5AB5-4B21-8BC5-0D42C7AA6788Q34389693-E555A2F2-57C8-495E-805C-D5D96CE5147FQ34467665-6CF12F22-46A6-4D5D-9326-AF51B7EE4234Q34535574-AB16F9B0-330F-4F26-BB7A-42E2C447407AQ34623871-C391990A-626E-45F5-86EE-AFF67172E04FQ34794074-BE128DDF-F95B-43EC-B18C-A9FE6C3CB6DCQ35079607-96E861E6-2DD4-4A8C-AB15-BCF5603163F7Q35106053-B3F4AA77-1316-4DF4-A45C-D7265F34EBD5Q35149124-4248598C-D825-4983-B932-EFCD7757200C
P2860
Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?
@en
type
label
Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?
@en
prefLabel
Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?
@en
P2093
P2860
P356
P1476
Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?
@en
P2093
Brigitte Kaissling
Michel Le Hir
Wilhelm Kriz
P2860
P304
P356
10.1172/JCI44595
P407
P577
2011-02-01T00:00:00Z